It is well known that NRG4, secreted in higher amounts by iBAT, inhibits hepatic de novo lipogenesis and expression of genes involved in this process, thus, establishing a crosstalk iBAT-liver that attenuates hepatic steatosis [38]. Here, NRG4 is linked to fatty liver disease.